New Biolimus Stent Equal to Everolimus Stent at One Year Science Daily (press release) The NEXT trial assigned 3,235 patients to either BES or an everolimus-eluting stent (EES) in the largest multicenter, randomized open-label study comparing these two devices ever reported. BES was approved in Japan in 2011, while EES is the country's ... NEXT: Biolimus-eluting stent comparable to everolimus-eluting stent at 1 year Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES |
